These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2744958)

  • 1. Ocular hypotensive effect of 8-hydroxycarteolol, a metabolite of carteolol.
    Sugiyama K; Enya T; Kitazawa Y
    Int Ophthalmol; 1989 Jan; 13(1-2):85-9. PubMed ID: 2744958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 8-hydroxycarteolol in normal human eyes].
    Kato Y; Sasaki T; Tsukahara S
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):899-903. PubMed ID: 1354411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of topical 8-hydroxy carteolol on intraocular pressure and melanin granules].
    Hirota A; Mishima H; Kiuchi Y; Nagata A; Kurokawa T; Ishibashi S
    Nippon Ganka Gakkai Zasshi; 1991 Aug; 95(8):752-7. PubMed ID: 1950831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma.
    Nakamoto K; Yasuda N
    Jpn J Ophthalmol; 2010 Mar; 54(2):140-3. PubMed ID: 20401563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension.
    Yamamoto T; Ikegami T; Ishikawa Y; Kikuchi S;
    Am J Ophthalmol; 2016 Nov; 171():35-46. PubMed ID: 27565224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of carteolol and timolol eyedrops on the pressure tolerance of the optic nerve head].
    Stodtmeister R; Pillunat L; Wilmanns I; Neubrand M; Finger B; Tobias G
    Ophthalmologica; 1989; 198(2):64-77. PubMed ID: 2710502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].
    Kitazawa Y; Azuma I; Takase M; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):798-804. PubMed ID: 7030018
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer.
    Tamaki Y; Araie M; Tomita K; Tomidokoro A; Nagahara M
    Surv Ophthalmol; 1997 Nov; 42 Suppl 1():S52-63. PubMed ID: 9603290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group.
    Stewart WC; Cohen JS; Netland PA; Weiss H; Nussbaum LL
    Am J Ophthalmol; 1997 Oct; 124(4):498-505. PubMed ID: 9323940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
    Sato T; Muto T; Ishibashi Y; Roy S
    Curr Eye Res; 2001 Oct; 23(4):298-306. PubMed ID: 11852432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure.
    Duff GR
    Acta Ophthalmol (Copenh); 1987 Oct; 65(5):618-21. PubMed ID: 3321878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea.
    Igarashi H; Katsuta Y; Sawa K; Nakazato Y; Kawasaki T
    Fundam Appl Toxicol; 1990 Apr; 14(3):554-9. PubMed ID: 2340982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of topical carteolol on tissue circulation in rabbit optic nerve head evaluated with the laser speckle microcirculation analyser].
    Tamaki Y; Tomita K; Araie M; Tomidokoro A; Nagahara M
    Nippon Ganka Gakkai Zasshi; 1995 Aug; 99(8):895-900. PubMed ID: 7676888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma.
    Haneda M; Shirato S; Maruyama K; Ohno Y
    Jpn J Ophthalmol; 2006; 50(1):33-7. PubMed ID: 16453185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery.
    Marchal-Heussler L; Sirbat D; Hoffman M; Maincent P
    Pharm Res; 1993 Mar; 10(3):386-90. PubMed ID: 8464811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1% carteolol hydrochloride eyedrops: long-term experience in the treatment of chronic open-angle glaucoma].
    van Husen H
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):491-5. PubMed ID: 3550260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
    Demailly P; Allaire C; Trinquand C;
    Br J Ophthalmol; 2001 Aug; 85(8):921-4. PubMed ID: 11466245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.